论文部分内容阅读
大剂量化疗和/或全身放射线照射(TBI)后行自身骨髓移植(ABMT)作为巩固治疗,这已来米越多地用于缓解后的急性髓系白血病(AML)的治疗。在欧洲大部分 AML 患者均进行 ABMT。本资料报道263例第1次缓解(CR_1)的 AML 患者进行 ABMT 的情况,旨在观察骨髓净化的作用。
The use of autologous bone marrow transplantation (ABMT) as a consolidation therapy after high-dose chemotherapy and / or total body irradiation (TBI) has been used more and more for the treatment of remitted acute myeloid leukemia (AML). ABMT is performed in most AML patients in Europe. This data reports the ABMT situation in 263 AML patients with first-responder (CR_1) AML, and aims to observe the role of bone marrow purification.